Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Bryson

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
International Journal of Technology Assessment in Health Care|December 14, 2016
ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDYMegan C Roberts, Amy Bryson, Morris Weinberger, et al.
Cancer Investigation|April 29, 2016
Patient-Centered Communication for Discussing Oncotype DX TestingMegan C Roberts, Amy Bryson, Morris Weinberger, et al.
Cancer Discovery|March 4, 2018
Colorectal Tumors Require NUAK1 for Protection from Oxidative StressJennifer Port, Nathiya Muthalagu, Meera Raja, et al.
Journal of Medicinal Chemistry|March 31, 2025
Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of RasCharles W Parry, Francesca Pellicano, Alexander W Schüttelkopf, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
International Journal of Technology Assessment in Health Care|December 14, 2016
ONCOLOGISTS' BARRIERS AND FACILITATORS FOR ONCOTYPE DX USE: QUALITATIVE STUDYMegan C Roberts, Amy Bryson, Morris Weinberger, et al.
Cancer Investigation|April 29, 2016
Patient-Centered Communication for Discussing Oncotype DX TestingMegan C Roberts, Amy Bryson, Morris Weinberger, et al.
Cancer Discovery|March 4, 2018
Colorectal Tumors Require NUAK1 for Protection from Oxidative StressJennifer Port, Nathiya Muthalagu, Meera Raja, et al.
Journal of Medicinal Chemistry|March 31, 2025
Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of RasCharles W Parry, Francesca Pellicano, Alexander W Schüttelkopf, et al.
Pageof 1